Crossmark

Addition of plerixafor to G-CSF is useful to achieve efficient collection even in very poor mobilizers: hope for patients with diminished hematopoietic function

Crossref DOI link: https://doi.org/10.1038/bmt.2017.80

Published Online: 2017-05-22

Published Print: 2017-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mohty, M

Drillat, P

Grouin, J-M

Bijou, F

Milpied, N

Chabannon, C
License Information

Text and Data Mining valid from 2017-05-22

Version of Record valid from 2017-05-22
More Information

Article History

First Online: 22 May 2017

Competing interests

: All authors declared that they have received lectures honoraria from Sanofi whose product is discussed in this study.

Document is current

Any future updates will be listed below